These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2157895)

  • 1. Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.
    Guo PX; Goebel S; Perkus ME; Taylor J; Norton E; Allen G; Languet B; Desmettre P; Paoletti E
    J Virol; 1990 May; 64(5):2399-406. PubMed ID: 2157895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.
    Guo PX; Goebel S; Davis S; Perkus ME; Languet B; Desmettre P; Allen G; Paoletti E
    J Virol; 1989 Oct; 63(10):4189-98. PubMed ID: 2550665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
    Osterrieder N; Wagner R; Brandmüller C; Schmidt P; Wolf H; Kaaden OR
    Virology; 1995 Apr; 208(2):500-10. PubMed ID: 7747423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcript analysis of the equine herpesvirus 1 glycoprotein B gene homologue and its expression by a recombinant vaccinia virus.
    Bell CW; Boyle DB; Whalley JM
    J Gen Virol; 1990 May; 71 ( Pt 5)():1119-29. PubMed ID: 2161047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1.
    Allen GP; Yeargan MR
    J Virol; 1987 Aug; 61(8):2454-61. PubMed ID: 3037108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the major glycoproteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3 using monoclonal antibodies.
    Crabb BS; Allen GP; Studdert MJ
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2075-82. PubMed ID: 1716650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model.
    Stokes A; Corteyn AH; Pullen LA; Doel TR; Meredith DM; Killington RA; Halliburton IW; Whittaker GR; Wheldon LA; Nicolson L
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():923-31. PubMed ID: 1707948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an equine herpesvirus type 1 gene encoding a glycoprotein (gp13) with homology to herpes simplex virus glycoprotein C.
    Allen GP; Coogle LD
    J Virol; 1988 Aug; 62(8):2850-8. PubMed ID: 2455821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models.
    Tsujimura K; Yamanaka T; Kondo T; Fukushi H; Matsumura T
    J Vet Med Sci; 2006 Oct; 68(10):1029-38. PubMed ID: 17085880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
    Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of equine herpesvirus type 1 glycoprotein gp14 in Escherichia coli and in insect cells: a comparative study on protein processing and humoral immune responses.
    Osterrieder N; Wagner R; Pfeffer M; Kaaden OR
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():2041-6. PubMed ID: 8046406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18.
    Stokes A; Allen GP; Pullen LA; Murray PK
    J Gen Virol; 1989 May; 70 ( Pt 5)():1173-83. PubMed ID: 2471805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus 1.
    Kydd JH; Davis-Poynter NJ; Birch J; Hannant D; Minke J; Audonnet JC; Antczak DF; Ellis SA
    J Gen Virol; 2006 Sep; 87(Pt 9):2507-2515. PubMed ID: 16894188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice.
    Csellner H; Walker C; Wellington JE; McLure LE; Love DN; Whalley JM
    Arch Virol; 2000; 145(11):2371-85. PubMed ID: 11205124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model.
    Tewari D; Whalley JM; Love DN; Field HJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1735-41. PubMed ID: 8021602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibodies against equine herpesvirus types 1 and 4 by using recombinant protein derived from an immunodominant region of glycoprotein B.
    Sinclair R; Binns MM; Chirnside ED; Mumford JA
    J Clin Microbiol; 1993 Feb; 31(2):265-71. PubMed ID: 8381809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.